Categories: News

Flexsys Announces Price Increase for Insoluble Sulfur in India

AKRON, Ohio, June 18, 2025 /PRNewswire/ — Flexsys has announced that it will increase the price of Insoluble Sulfur products sold in India by $0.25/kg, effective for all shipments on or after July 1, 2025, or as permitted by customer contracts. This adjustment is attributed to elevated raw material costs, evolving market conditions, and increased investments in research and development aimed at producing innovative, sustainable, and higher-performing products.

- Advertisement -

About Flexsys

- Advertisement -

Flexsys is a global specialty chemicals and materials technology company dedicated to innovating and producing a range of tire additives. Our mission is to enable tire companies to enhance tire performance and manufacturing productivity while promoting sustainability through innovation. Headquartered in Akron, Ohio, with manufacturing facilities across North America, South America, Europe, and Asia, our global team is committed to ensuring the success of our customers.

- Advertisement -

www.flexsys.com

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/flexsys-announces-price-increase-for-insoluble-sulfur-in-india-302484468.html

- Advertisement -

Recent Posts

Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment

Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van…

48 minutes ago

Kia Launches Inspiration Connects Us All Campaign Ahead of FIFA World Cup 2026

New campaign highlights Kia’s commitment to promoting unity and connection for people around the worldKia…

48 minutes ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine…

2 hours ago

Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders

BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than…

2 hours ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction…

2 hours ago

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment…

2 hours ago